دورية أكاديمية

Compared to oxcarbazepine and carbamazepine, botulinum toxin type A is a useful therapeutic option for trigeminal neuralgia symptoms: A systematic review.

التفاصيل البيبلوغرافية
العنوان: Compared to oxcarbazepine and carbamazepine, botulinum toxin type A is a useful therapeutic option for trigeminal neuralgia symptoms: A systematic review.
المؤلفون: Naderi Y; Oral and Dental Diseases Research Center, Kerman University of Medical Sciences, Kerman, Iran., Rad M; Oral and Dental Diseases Research Center, Kerman University of Medical Sciences, Kerman, Iran., Sadatmoosavi A; Research Center for Modeling in Health, Kerman University of Medical Sciences, Kerman, Iran., Khaleghi E; Research Center for Modeling in Health, Kerman University of Medical Sciences, Kerman, Iran., Khorrami Z; Ophthalmic Epidemiology Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Science, Tehran, Iran., Chamani G; Department of Dental Medicine, Karolinska Institute, Scandinavian Center for Orofacial Neuroscience (SCON), Huddinge, Sweden., Shabani M; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran.
المصدر: Clinical and experimental dental research [Clin Exp Dent Res] 2024 Apr; Vol. 10 (2), pp. e882.
نوع المنشور: Systematic Review; Journal Article; Comparative Study; Review
اللغة: English
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101692332 Publication Model: Print Cited Medium: Internet ISSN: 2057-4347 (Electronic) Linking ISSN: 20574347 NLM ISO Abbreviation: Clin Exp Dent Res
أسماء مطبوعة: Original Publication: Hoboken : Wiley, [2015]-
مواضيع طبية MeSH: Trigeminal Neuralgia*/drug therapy , Carbamazepine*/therapeutic use , Oxcarbazepine*/therapeutic use , Botulinum Toxins, Type A*/therapeutic use , Botulinum Toxins, Type A*/administration & dosage, Humans ; Treatment Outcome ; Neuromuscular Agents/therapeutic use ; Neuromuscular Agents/administration & dosage ; Anticonvulsants/therapeutic use
مستخلص: Objectives: This review aimed to compare the effectiveness of three treatments: BTX A, CBZ, and OXB, in managing trigeminal neuralgia (TN).
Material and Methods: We conducted a thorough search for research articles related to our issue using specific keywords on several databases, including Cochrane Central Register of Controlled Trials, Science Direct, Scopus, PubMed, Elsevier, Springer Journals, Ovid Medline, EBSCO, and Web of Science. Our focus was on publications from 1965 to 2023.
Results: We retrieved 46 articles from the search and reviewed them carefully. Out of these, we selected 29 articles that met the inclusion criteria. Among the selected articles, 11 investigated the effects of CBZ and OXB, while 18 explored the impact of BTX A on the improvement of TN symptoms. The response rate ranged between 56% and 90.5% for CBZ and between 90.9% and 94% for OXB. The response rate for BTX A ranged between 51.4% and 100%. All these three treatments had a remarkable effect on the improvement of TN. Importantly, findings highlighted that side effects of CBZ and OXB could lead to treatment discontinuation in some cases, whereas BTX A's side effects have been minimal and less frequent.
Conclusions: Consequently, BTX A emerges as a promising alternative for TN treatment. However, additional clinical trials are necessary to validate this finding, and further research is required to establish a standardized protocol for administering BTX A in TN.
(© 2024 The Authors. Clinical and Experimental Dental Research published by John Wiley & Sons Ltd.)
References: Cephalalgia. 2012 Apr;32(6):443-50. (PMID: 22492424)
J Dent (Shiraz). 2014 Sep;15(3):140-6. (PMID: 25191664)
Ann Surg. 2006 Nov;244(5):663-7. (PMID: 17060756)
Pain Res Treat. 2013;2013:831094. (PMID: 24194982)
J Neurosci Rural Pract. 2018 Jan-Mar;9(1):100-105. (PMID: 29456352)
J Headache Pain. 2015;16:563. (PMID: 26335440)
Cephalalgia. 1986 Sep;6(3):181-2. (PMID: 3533272)
Cochrane Database Syst Rev. 2011 Jan 19;(1):CD005451. (PMID: 21249671)
Phys Ther. 2008 Feb;88(2):156-75. (PMID: 18073267)
Brain. 2000 Apr;123 ( Pt 4):665-76. (PMID: 10733998)
World Neurosurg. 2021 May;149:e63-e70. (PMID: 33647489)
J Headache Pain. 2014 Jun 22;15:43. (PMID: 24952600)
J Neurol Neurosurg Psychiatry. 1966 Jun;29(3):265-7. (PMID: 5327969)
BMC Oral Health. 2020 Sep 3;20(1):244. (PMID: 32883250)
J Headache Pain. 2014 Jun 09;15:34. (PMID: 24912658)
J Pain Res. 2010 Oct 25;3:201-12. (PMID: 21197324)
Medicine (Baltimore). 2017 Sep;96(39):e8133. (PMID: 28953646)
Br J Neurosurg. 2007 Jun;21(3):253-61. (PMID: 17612914)
J Investig Clin Dent. 2012 May;3(2):98-102. (PMID: 22180190)
Headache. 1969 Apr;9(1):54-7. (PMID: 4896266)
Int J Neurosci. 2016;126(4):348-53. (PMID: 26000810)
Drugs. 2014 Jul;74(11):1165-76. (PMID: 25030431)
J Neurol. 2004 Feb;251 Suppl 1:I1-7. (PMID: 14991335)
Pain Res Manag. 2018 Apr 5;2018:7365148. (PMID: 29849847)
Neurol Sci. 2005 May;26 Suppl 2:s150-1. (PMID: 15926016)
J Craniofac Surg. 2021 Nov-Dec 01;32(8):e834. (PMID: 34292248)
J Headache Pain. 2007 Feb;8(1):19-27. (PMID: 17221345)
Headache. 1969 Apr;9(1):64-72. (PMID: 4896267)
Ann Neurol. 1990 Jan;27(1):89-95. (PMID: 2301931)
Curr Pain Headache Rep. 2010 Jun;14(3):189-95. (PMID: 20425191)
Neurosurg Rev. 2021 Apr;44(2):1119-1125. (PMID: 32333283)
Eur J Neurol. 2019 Jun;26(6):831-849. (PMID: 30860637)
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Jan;111(1):47-50. (PMID: 20674409)
J Chin Med Assoc. 2011 Jun;74(6):243-9. (PMID: 21621166)
Cephalalgia. 2017 Jun;37(7):648-657. (PMID: 28076964)
Expert Opin Pharmacother. 2006 Jun;7(8):1085-95. (PMID: 16722818)
Clin J Pain. 2018 Jul;34(7):685-690. (PMID: 29200017)
J Dermatol. 2021 Aug;48(8):e388-e389. (PMID: 34041793)
Niger J Surg. 2018 Jul-Dec;24(2):95-99. (PMID: 30283219)
Postgrad Med J. 1981 Jan;57(663):16-8. (PMID: 7279817)
Cephalalgia. 2011 Nov;31(15):1542-8. (PMID: 21960648)
Headache. 2019 Sep;59(8):1229-1239. (PMID: 31342515)
Acta Neurol Scand Suppl. 1983;97:69-80. (PMID: 6424398)
Headache. 2014 Nov-Dec;54(10):1574-82. (PMID: 25231219)
J Pain Res. 2018 Oct 12;11:2343-2351. (PMID: 30349359)
J Headache Pain. 2017 Aug 10;18(1):81. (PMID: 28799056)
Headache. 2013 Sep;53 Suppl 2:54-61. (PMID: 24024603)
Med Clin (Barc). 2017 Jan 6;148(1):28-32. (PMID: 27743594)
J Clin Exp Dent. 2015 Feb 01;7(1):e40-4. (PMID: 25810840)
Exp Ther Med. 2019 Nov;18(5):3375-3382. (PMID: 31602211)
J Oral Facial Pain Headache. 2019 Sep 27;34(2):135–140. (PMID: 31560737)
Toxins (Basel). 2021 Aug 29;13(9):. (PMID: 34564609)
J Headache Pain. 2013 Nov 19;14:92. (PMID: 24251833)
Arq Neuropsiquiatr. 2008 Sep;66(3A):500-3. (PMID: 18813708)
Clin J Pain. 2018 Aug;34(8):691-699. (PMID: 29443722)
Neurology. 2005 Oct 25;65(8):1306-8. (PMID: 16247065)
J Headache Pain. 2014 Sep 27;15:65. (PMID: 25263254)
Clin Neurol Neurosurg. 2012 Feb;114(2):101-7. (PMID: 22130044)
J Headache Pain. 2017 Dec;18(1):38. (PMID: 28324318)
J Pain Res. 2019 Jul 17;12:2177-2186. (PMID: 31410051)
Pain Med. 2020 Aug 1;21(8):1611-1615. (PMID: 32167549)
Eur J Pain. 2021 May;25(5):1064-1071. (PMID: 33428801)
J Neurol Neurosurg Psychiatry. 1989 Apr;52(4):472-6. (PMID: 2738589)
Clin Nutr. 2011 Dec;30(6):730-7. (PMID: 21704437)
J Pain Symptom Manage. 2003 May;25(5 Suppl):S31-5. (PMID: 12694990)
Zhongguo Dang Dai Er Ke Za Zhi. 2015 Apr;17(4):414-9. (PMID: 25919567)
Arch Neurol. 1989 Sep;46(9):960-3. (PMID: 2673161)
Pain. 2009 Jan;141(1-2):60-9. (PMID: 19004549)
Cephalalgia. 2004;24 Suppl 1:9-160. (PMID: 14979299)
Nutrients. 2014 May 30;6(6):2148-64. (PMID: 24886987)
Semin Neurol. 2016 Feb;36(1):73-83. (PMID: 26866499)
J Clin Neurosci. 2008 May;15(5):516-9. (PMID: 18378142)
معلومات مُعتمدة: None
فهرسة مساهمة: Keywords: botulinum toxin type A; carbamazepine; oxcarbazepine; trigeminal neuralgia
المشرفين على المادة: 33CM23913M (Carbamazepine)
VZI5B1W380 (Oxcarbazepine)
EC 3.4.24.69 (Botulinum Toxins, Type A)
0 (Neuromuscular Agents)
0 (Anticonvulsants)
تواريخ الأحداث: Date Created: 20240401 Date Completed: 20240807 Latest Revision: 20240807
رمز التحديث: 20240808
مُعرف محوري في PubMed: PMC10982606
DOI: 10.1002/cre2.882
PMID: 38558383
قاعدة البيانات: MEDLINE
الوصف
تدمد:2057-4347
DOI:10.1002/cre2.882